 | • レポートコード：MRC2-11QY11204 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支拡張症治療のグローバル市場について調査・分析したレポートです。種類別（硫酸アミカシン、ARD-3150、CHF-6333、塩酸シプロフロキサシン、ドキソフィリン、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支拡張症治療の競争状況、市場シェア ・世界の気管支拡張症治療市場：種類別市場規模 2015年-2020年（硫酸アミカシン、ARD-3150、CHF-6333、塩酸シプロフロキサシン、ドキソフィリン、その他） ・世界の気管支拡張症治療市場：種類別市場規模予測 2021年-2026年（硫酸アミカシン、ARD-3150、CHF-6333、塩酸シプロフロキサシン、ドキソフィリン、その他） ・世界の気管支拡張症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の気管支拡張症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の気管支拡張症治療市場分析：米国、カナダ ・ヨーロッパの気管支拡張症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支拡張症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支拡張症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支拡張症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Aradigm Corporation、Fisher & Paykel Healthcare Corporation、Zambon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Bad breath, wheezing chest and recurrent lung infections are some of the other symptoms witnessed by bronchiectasis patients. Occurrence of this condition is more prominent in children. Pneumonia along with cystic fibrosis, immune deficiency and others are known to cause bronchiectasis. Blood tests, chest x-ray, CT scan and spirometry are some of the diagnostic methodologies employed to determine this condition.
The major factors driving the growth of the market are consistent rise in the patients suffering from respiratory ailments, technological advances and increased participation of the market players in research and development. On the contrary, lack of specificity in treatment, strict regulatory policies and high costs involved in research and development are some of the factors that might restrain the growth of the market.
Market Analysis and Insights: Global Bronchiectasis Treatment Market
The global Bronchiectasis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bronchiectasis Treatment Scope and Market Size
Bronchiectasis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchiectasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
Aradigm Corporation
Fisher & Paykel Healthcare Corporation
Zambon
…
Market segment by Type, the product can be split into
Amikacin Sulfate
ARD-3150
CHF-6333
Ciprofloxacin Hydrochloride
Doxofylline
Others
Market segment by Application, split into
Clinic
Hospital
Homecare
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bronchiectasis Treatment Revenue
1.4 Market by Type
1.4.1 Global Bronchiectasis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Amikacin Sulfate
1.4.3 ARD-3150
1.4.4 CHF-6333
1.4.5 Ciprofloxacin Hydrochloride
1.4.6 Doxofylline
1.4.7 Others
1.5 Market by Application
1.5.1 Global Bronchiectasis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Treatment Market Perspective (2015-2026)
2.2 Global Bronchiectasis Treatment Growth Trends by Regions
2.2.1 Bronchiectasis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bronchiectasis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bronchiectasis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bronchiectasis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bronchiectasis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Treatment Players by Market Size
3.1.1 Global Top Bronchiectasis Treatment Players by Revenue (2015-2020)
3.1.2 Global Bronchiectasis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bronchiectasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bronchiectasis Treatment Market Concentration Ratio
3.2.1 Global Bronchiectasis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bronchiectasis Treatment Revenue in 2019
3.3 Bronchiectasis Treatment Key Players Head office and Area Served
3.4 Key Players Bronchiectasis Treatment Product Solution and Service
3.5 Date of Enter into Bronchiectasis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchiectasis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bronchiectasis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bronchiectasis Treatment Market Size by Application (2015-2020)
5.2 Global Bronchiectasis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bronchiectasis Treatment Market Size (2015-2020)
6.2 Bronchiectasis Treatment Key Players in North America (2019-2020)
6.3 North America Bronchiectasis Treatment Market Size by Type (2015-2020)
6.4 North America Bronchiectasis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bronchiectasis Treatment Market Size (2015-2020)
7.2 Bronchiectasis Treatment Key Players in Europe (2019-2020)
7.3 Europe Bronchiectasis Treatment Market Size by Type (2015-2020)
7.4 Europe Bronchiectasis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Bronchiectasis Treatment Market Size (2015-2020)
8.2 Bronchiectasis Treatment Key Players in China (2019-2020)
8.3 China Bronchiectasis Treatment Market Size by Type (2015-2020)
8.4 China Bronchiectasis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bronchiectasis Treatment Market Size (2015-2020)
9.2 Bronchiectasis Treatment Key Players in Japan (2019-2020)
9.3 Japan Bronchiectasis Treatment Market Size by Type (2015-2020)
9.4 Japan Bronchiectasis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bronchiectasis Treatment Market Size (2015-2020)
10.2 Bronchiectasis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bronchiectasis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bronchiectasis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Bronchiectasis Treatment Market Size (2015-2020)
11.2 Bronchiectasis Treatment Key Players in India (2019-2020)
11.3 India Bronchiectasis Treatment Market Size by Type (2015-2020)
11.4 India Bronchiectasis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bronchiectasis Treatment Market Size (2015-2020)
12.2 Bronchiectasis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bronchiectasis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bronchiectasis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Bronchiectasis Treatment Introduction
13.1.4 AstraZeneca Revenue in Bronchiectasis Treatment Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Aradigm Corporation
13.2.1 Aradigm Corporation Company Details
13.2.2 Aradigm Corporation Business Overview
13.2.3 Aradigm Corporation Bronchiectasis Treatment Introduction
13.2.4 Aradigm Corporation Revenue in Bronchiectasis Treatment Business (2015-2020)
13.2.5 Aradigm Corporation Recent Development
13.3 Fisher & Paykel Healthcare Corporation
13.3.1 Fisher & Paykel Healthcare Corporation Company Details
13.3.2 Fisher & Paykel Healthcare Corporation Business Overview
13.3.3 Fisher & Paykel Healthcare Corporation Bronchiectasis Treatment Introduction
13.3.4 Fisher & Paykel Healthcare Corporation Revenue in Bronchiectasis Treatment Business (2015-2020)
13.3.5 Fisher & Paykel Healthcare Corporation Recent Development
13.4 Zambon
13.4.1 Zambon Company Details
13.4.2 Zambon Business Overview
13.4.3 Zambon Bronchiectasis Treatment Introduction
13.4.4 Zambon Revenue in Bronchiectasis Treatment Business (2015-2020)
13.4.5 Zambon Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bronchiectasis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bronchiectasis Treatment Revenue
Table 3. Ranking of Global Top Bronchiectasis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bronchiectasis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Amikacin Sulfate
Table 6. Key Players of ARD-3150
Table 7. Key Players of CHF-6333
Table 8. Key Players of Ciprofloxacin Hydrochloride
Table 9. Key Players of Doxofylline
Table 10. Key Players of Others
Table 11. Global Bronchiectasis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Bronchiectasis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Bronchiectasis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Bronchiectasis Treatment Market Share by Regions (2015-2020)
Table 15. Global Bronchiectasis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Bronchiectasis Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Bronchiectasis Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Bronchiectasis Treatment Players
Table 22. Global Bronchiectasis Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Bronchiectasis Treatment Market Share by Players (2015-2020)
Table 24. Global Top Bronchiectasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Treatment as of 2019)
Table 25. Global Bronchiectasis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Bronchiectasis Treatment Product Solution and Service
Table 28. Date of Enter into Bronchiectasis Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Bronchiectasis Treatment Market Size Share by Type (2015-2020)
Table 32. Global Bronchiectasis Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Bronchiectasis Treatment Market Size Share by Application (2015-2020)
Table 34. Global Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Bronchiectasis Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 38. North America Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 40. North America Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 44. Europe Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 46. Europe Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 50. China Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 52. China Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 56. Japan Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 58. Japan Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 62. Southeast Asia Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 68. India Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 70. India Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Bronchiectasis Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Bronchiectasis Treatment Market Share (2019-2020)
Table 74. Central & South America Bronchiectasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Bronchiectasis Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Bronchiectasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Bronchiectasis Treatment Market Share by Application (2015-2020)
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Product
Table 81. AstraZeneca Revenue in Bronchiectasis Treatment Business (2015-2020) (Million US$)
Table 82. AstraZeneca Recent Development
Table 83. Aradigm Corporation Company Details
Table 84. Aradigm Corporation Business Overview
Table 85. Aradigm Corporation Product
Table 86. Aradigm Corporation Revenue in Bronchiectasis Treatment Business (2015-2020) (Million US$)
Table 87. Aradigm Corporation Recent Development
Table 88. Fisher & Paykel Healthcare Corporation Company Details
Table 89. Fisher & Paykel Healthcare Corporation Business Overview
Table 90. Fisher & Paykel Healthcare Corporation Product
Table 91. Fisher & Paykel Healthcare Corporation Revenue in Bronchiectasis Treatment Business (2015-2020) (Million US$)
Table 92. Fisher & Paykel Healthcare Corporation Recent Development
Table 93. Zambon Company Details
Table 94. Zambon Business Overview
Table 95. Zambon Product
Table 96. Zambon Revenue in Bronchiectasis Treatment Business (2015-2020) (Million US$)
Table 97. Zambon Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiectasis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Amikacin Sulfate Features
Figure 3. ARD-3150 Features
Figure 4. CHF-6333 Features
Figure 5. Ciprofloxacin Hydrochloride Features
Figure 6. Doxofylline Features
Figure 7. Others Features
Figure 8. Global Bronchiectasis Treatment Market Share by Application: 2020 VS 2026
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Homecare Case Studies
Figure 12. Bronchiectasis Treatment Report Years Considered
Figure 13. Global Bronchiectasis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Bronchiectasis Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Bronchiectasis Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Bronchiectasis Treatment Market Share by Players in 2019
Figure 18. Global Top Bronchiectasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Bronchiectasis Treatment Revenue in 2019
Figure 20. North America Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Bronchiectasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
若年性黄斑変性症治療の世界市場（～2026年） Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Juvenile Macular Degeneration Treat…- 統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
- 野兎病治療の世界市場（～2026年） Market Analysis and Insights: Global Tularaemia Treatment Market The global Tularaemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tularaemia Treatment Scope and Market Size Tularaemia Treatment market is…
- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …
- 軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…